Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Web-based Symptom Monitoring and Survival in Advanced Stage Lung Cancer

NCT05621902 is registered in ClinicalTrials.gov with Mats Lambe as lead sponsor.

NCT NCT05621902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05621902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Web-based Symptom Monitoring and Survival in Advanced Stage Lung Cancer
Lead sponsor
Mats Lambe
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 18, 2022
Completion date
June 30, 2027
Enrollment
398 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer